To include your compound in the COVID-19 Resource Center, submit it here.
Unity Biotechnology Inc. (San Francisco, Calif.) raised $55 million in a series C round. New
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury